357 related articles for article (PubMed ID: 27821106)
1. Aberrant activation of Notch signaling in extrahepatic cholangiocarcinoma: clinicopathological features and therapeutic potential for cancer stem cell-like properties.
Aoki S; Mizuma M; Takahashi Y; Haji Y; Okada R; Abe T; Karasawa H; Tamai K; Okada T; Morikawa T; Hayashi H; Nakagawa K; Motoi F; Naitoh T; Katayose Y; Unno M
BMC Cancer; 2016 Nov; 16(1):854. PubMed ID: 27821106
[TBL] [Abstract][Full Text] [Related]
2. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44
Barat S; Chen X; Cuong Bui K; Bozko P; Götze J; Christgen M; Krech T; Malek NP; Plentz RR
Stem Cells Transl Med; 2017 Mar; 6(3):819-829. PubMed ID: 28186678
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties.
Wang M; Xiao J; Shen M; Yahong Y; Tian R; Zhu F; Jiang J; Du Z; Hu J; Liu W; Qin R
Int J Cancer; 2011 Jan; 128(1):72-81. PubMed ID: 20232394
[TBL] [Abstract][Full Text] [Related]
4. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
[TBL] [Abstract][Full Text] [Related]
5. Curcumin-mediated regulation of Notch1/hairy and enhancer of split-1/survivin: molecular targeting in cholangiocarcinoma.
Koprowski S; Sokolowski K; Kunnimalaiyaan S; Gamblin TC; Kunnimalaiyaan M
J Surg Res; 2015 Oct; 198(2):434-40. PubMed ID: 25890434
[TBL] [Abstract][Full Text] [Related]
6. microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway.
Qiao P; Li G; Bi W; Yang L; Yao L; Wu D
BMC Cancer; 2015 Jun; 15():469. PubMed ID: 26077733
[TBL] [Abstract][Full Text] [Related]
7. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.
Ibrahim SA; Gadalla R; El-Ghonaimy EA; Samir O; Mohamed HT; Hassan H; Greve B; El-Shinawi M; Mohamed MM; Götte M
Mol Cancer; 2017 Mar; 16(1):57. PubMed ID: 28270211
[TBL] [Abstract][Full Text] [Related]
8. MAML1 regulates cell viability via the NF-κB pathway in cervical cancer cell lines.
Kuncharin Y; Sangphech N; Kueanjinda P; Bhattarakosol P; Palaga T
Exp Cell Res; 2011 Aug; 317(13):1830-40. PubMed ID: 21640102
[TBL] [Abstract][Full Text] [Related]
9. Activation of Notch signaling is required for cholangiocarcinoma progression and is enhanced by inactivation of p53 in vivo.
El Khatib M; Bozko P; Palagani V; Malek NP; Wilkens L; Plentz RR
PLoS One; 2013; 8(10):e77433. PubMed ID: 24204826
[TBL] [Abstract][Full Text] [Related]
10. Corilagin suppresses cholangiocarcinoma progression through Notch signaling pathway in vitro and in vivo.
Gu Y; Xiao L; Ming Y; Zheng Z; Li W
Int J Oncol; 2016 May; 48(5):1868-76. PubMed ID: 26935808
[TBL] [Abstract][Full Text] [Related]
11. GSI-I has a better effect in inhibiting hepatocellular carcinoma cell growth than GSI-IX, GSI-X, or GSI-XXI.
Shen Y; Lv D; Wang J; Yin Y; Miao F; Dou F; Zhang J
Anticancer Drugs; 2012 Aug; 23(7):683-90. PubMed ID: 22569108
[TBL] [Abstract][Full Text] [Related]
12. Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells.
Ponnurangam S; Dandawate PR; Dhar A; Tawfik OW; Parab RR; Mishra PD; Ranadive P; Sharma R; Mahajan G; Umar S; Weir SJ; Sugumar A; Jensen RA; Padhye SB; Balakrishnan A; Anant S; Subramaniam D
Oncotarget; 2016 Jan; 7(3):3217-32. PubMed ID: 26673007
[TBL] [Abstract][Full Text] [Related]
13. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy.
Liu J; Mao Z; Huang J; Xie S; Liu T; Mao Z
Biochem Biophys Res Commun; 2014 Feb; 444(4):670-5. PubMed ID: 24502949
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of altered Notch signaling in extrahepatic cholangiocarcinoma and gallbladder carcinoma.
Yoon HA; Noh MH; Kim BG; Han JS; Jang JS; Choi SR; Jeong JS; Chun JH
World J Gastroenterol; 2011 Sep; 17(35):4023-30. PubMed ID: 22046092
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance of aberrant Notch receptors in intrahepatic cholangiocarcinoma.
Wu WR; Shi XD; Zhang R; Zhu MS; Xu LB; Yu XH; Zeng H; Wang J; Liu C
Int J Clin Exp Pathol; 2014; 7(6):3272-9. PubMed ID: 25031748
[TBL] [Abstract][Full Text] [Related]
16. Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications.
Wu HJ; Chu PY
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450710
[TBL] [Abstract][Full Text] [Related]
17. Loss of Numb promotes hepatic progenitor expansion and intrahepatic cholangiocarcinoma by enhancing Notch signaling.
Shu Y; Xu Q; Xu Y; Tao Q; Shao M; Cao X; Chen Y; Wu Z; Chen M; Zhou Y; Zhou P; Shi Y; Bu H
Cell Death Dis; 2021 Oct; 12(11):966. PubMed ID: 34667161
[TBL] [Abstract][Full Text] [Related]
18. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
Bi YL; Min M; Shen W; Liu Y
Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287
[TBL] [Abstract][Full Text] [Related]
19. Human G-protein gamma 7 in extrahepatic cholangiocarcinoma and its clinicopathological significance.
Wang M; Gong B; Li Y; Wang Y
Hematol Oncol Stem Cell Ther; 2010; 3(2):66-70. PubMed ID: 20543539
[TBL] [Abstract][Full Text] [Related]
20. Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae.
Hsu EC; Kulp SK; Huang HL; Tu HJ; Salunke SB; Sullivan NJ; Sun D; Wicha MS; Shapiro CL; Chen CS
Neoplasia; 2015 Jun; 17(6):497-508. PubMed ID: 26152358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
